TNF and inflammatory bowel disease: As TNF‐α plays a central role in the regulation of inflammation, TNF‐blocking biologicals are already approved for the treatment of inflammatory diseases including rheumatoid arthritis, inflammatory bowel disease, and psoriasis 37, 38.